Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals
- Savas I.N. , et al.
2. An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
- Armandi A. , et al.
3. The Predictive Role of Osteopontin Level in Patients with Type 2 Diabetes Mellitus without Fatty Liver Disease
- Kadhum Q.K. , et al.
4. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis
- Omar M.A. , et al.
5. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
- Yang T. , et al.
6. Diagnostic accuracy and prognostic significance of osteopontin in liver cirrhosis and hepatocellular carcinoma: a Meta-analysis
- Zhang Y. , et al.
7. Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy
- Mukherjee B. , et al.
8. Performance of SPINK1 and SPINK1-based diagnostic model in detection of hepatocellular carcinoma
- Wang F. , et al.
9. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
- Colli A. , et al.
10. Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study
- Caserza L. , et al.
11. Proteomic profiling and artificial intelligence for hepatocellular carcinoma translational medicine
- Moldogazieva N.T. , et al.
12. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
- Zhang J. , et al.
13. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- Wang C. , et al.
14. Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients
- Hanno A.E.F.F. , et al.
15. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus
- Sobhy A. , et al.
16. Evaluation of click chemistry microarrays for immunosensing
- Dadfar S.M.M. , et al.
17. Biomarkers in diagnosis and prediction of hepatocellular carcinoma recurrence
- Malov S.I. , et al.
18. Molecular diagnosis of hepatocellular carcinoma: trends in biomarkers combination to enhance early cancer detection
- Chia T.S. , et al.
19. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
- Menyhárt O. , et al.
20. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: A meta-analysis
- Sun T. , et al.
21. Discovery of a potential plasma protein biomarker panel for acute-on-chronic liver failure induced by hepatitis B virus
- Zhou N. , et al.
22. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up
- Cabiati M. , et al.